S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:CAN

Canaan (CAN) Stock Price, News & Analysis

$0.75
-0.17 (-18.43%)
(As of 04/19/2024 ET)
Today's Range
$0.75
$0.98
50-Day Range
$0.92
$2.31
52-Week Range
$0.75
$3.50
Volume
19.19 million shs
Average Volume
17.66 million shs
Market Capitalization
$175.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.25

Canaan MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
465.5% Upside
$4.25 Price Target
Short Interest
Bearish
11.51% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.54mentions of Canaan in the last 14 days
Based on 18 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.95 out of 5 stars

Computer And Technology Sector

435th out of 582 stocks

Semiconductors & Related Devices Industry

71st out of 88 stocks

CAN stock logo

About Canaan Stock (NASDAQ:CAN)

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

CAN Stock Price History

CAN Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Canaan Target of Unusually Large Options Trading (NASDAQ:CAN)
Canaan Shines at Blockchain Life 2024 in Dubai
Why Is Canaan (CAN) Stock Down 21% Today?
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Canaan Inc. Files 2023 Annual Report on Form 20-F
3 Escape New Canaan House Fire
See More Headlines
Receive CAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Canaan and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/19/2024
Next Earnings (Estimated)
5/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
N/A
Current Symbol
NASDAQ:CAN
Fax
N/A
Employees
541
Year Founded
2013

Price Target and Rating

Average Stock Price Target
$4.25
High Stock Price Target
$5.50
Low Stock Price Target
$3.00
Potential Upside/Downside
+380.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-414,150,000.00
Net Margins
-195.84%
Pretax Margin
-220.12%

Debt

Sales & Book Value

Annual Sales
$211.48 million
Cash Flow
$0.58 per share
Book Value
$1.49 per share

Miscellaneous

Free Float
232,823,000
Market Cap
$206.69 million
Optionable
Optionable
Beta
3.01

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

CAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Canaan stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canaan in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CAN shares.
View CAN analyst ratings
or view top-rated stocks.

What is Canaan's stock price target for 2024?

2 Wall Street analysts have issued 1 year target prices for Canaan's stock. Their CAN share price targets range from $3.00 to $5.50. On average, they anticipate the company's stock price to reach $4.25 in the next year. This suggests a possible upside of 465.5% from the stock's current price.
View analysts price targets for CAN
or view top-rated stocks among Wall Street analysts.

How have CAN shares performed in 2024?

Canaan's stock was trading at $2.31 on January 1st, 2024. Since then, CAN shares have decreased by 67.5% and is now trading at $0.7516.
View the best growth stocks for 2024 here
.

Are investors shorting Canaan?

Canaan saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 26,870,000 shares, an increase of 15.8% from the March 15th total of 23,200,000 shares. Based on an average daily trading volume, of 18,120,000 shares, the days-to-cover ratio is currently 1.5 days.
View Canaan's Short Interest
.

When is Canaan's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024.
View our CAN earnings forecast
.

How were Canaan's earnings last quarter?

Canaan Inc. (NASDAQ:CAN) announced its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.35) EPS for the quarter, meeting analysts' consensus estimates of ($0.35). The firm earned $49.07 million during the quarter, compared to analyst estimates of $33.90 million. Canaan had a negative trailing twelve-month return on equity of 80.13% and a negative net margin of 195.84%.

What guidance has Canaan issued on next quarter's earnings?

Canaan issued an update on its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $33.0 million-$33.0 million, compared to the consensus revenue estimate of $43.1 million.

When did Canaan IPO?

Canaan (CAN) raised $100 million in an initial public offering (IPO) on Thursday, November 21st 2019. The company issued 10,000,000 shares at $9.00-$11.00 per share. Citigroup, China Renaissance and CMBI acted as the underwriters for the IPO and Galaxy Digital Advisors, Huatai Securities and Tiger Brokers were co-managers.

Who are Canaan's major shareholders?

Canaan's stock is owned by a variety of institutional and retail investors. Top institutional investors include IMC Chicago LLC (0.00%).

How do I buy shares of Canaan?

Shares of CAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Canaan have any subsidiaries?
The following companies are subsidiares of Canaan: Canaan Bright Sight Co. Ltd., Canaan Convey Co. Ltd., Canaan Creative (HK) Holdings Limited, Canaan Creative (SH) Co. Ltd., Canaan Creative Co. Ltd., Canaan Creative International PTE. Ltd., Hangzhou Canaan Chuangxin Technology Co. Ltd., Hangzhou Canaan Intelligence Information Technology Co. Ltd., Langfang Creative Technology Co. Ltd., Proof of Existence, and Zhejiang Avalon Technology Co. Ltd..
Read More
This page (NASDAQ:CAN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners